BMJ: 证据来了!6个月低碳水饮食可有效改善糖尿病!

2021-06-05 MedSci原创 MedSci原创

坚持6个月低碳水饮食的患者糖尿病的缓解率较高,而不会产生不良后果。

低碳水化合物饮食,又称低糖饮食,是限制碳水化合物(糖类)摄入量的饮食方案,通常用于治疗肥胖或糖尿病此饮食会限制精致碳水化合物的摄取(例如糖、面包、面食),改为食用蛋白质和脂类百分比高的食品(例如肉类、禽类、贝类、蛋类、奶酪、坚果、植物籽实类或花生)以及其他低碳水化合物的食品(如大多数拌沙律的蔬菜)。低碳水化合物饮食也允许食用其他类蔬菜和水果(特别是浆果类)。不同的低碳水化合物饮食方案允许食用的碳水化合物的量不同。

这种饮食有时是生酮饮食(限制碳水化合物的摄入量直到身体出现酮症),如阿特金斯健康饮食法的诱导阶段即为生酮饮食。不过,一些文献把某些限制变量较少的饮食方案也看作为“低碳水化合物”饮食方案。

除了治疗肥胖症以外,低碳水化合物饮食也用于治疗其他疾病,特别值得提出的是改善糖尿病和癫痫病但也用于治疗慢性疲劳综合症和多囊卵巢综合症以及癌症。

近期,为了确定低碳水化合物饮食(LCD)和极低碳水化合物饮食(VLCD)对2型糖尿病(T2DM)患者的疗效和安全性,来自美国德克萨斯A&M大学营养学专家展开了系统回顾和荟萃分析,结果发表在《英国医学杂志》BMJ上。

研究人员搜索CENTRAL、Medline、Embase、CINAHL、CAB等数据库文献来源,主要选择对T2DM患者的LCD(<130克/天或<26%的2000千卡/天的饮食)和VLCD(<10%的碳水化合物热量)进行评估至少12周的随机临床试验。

主要的实验设计图

主要结果是糖尿病的缓解(HbA1c<6.5%或空腹血糖<7.0mmol/L)、体重减轻、HbA1c、空腹血糖和不良事件。次要结果包括与健康有关的生活质量和生化指标。

共搜索确定了14759篇文献,纳入23项试验(1357名参与者),40.6%的结果被判定为低偏倚风险。在6个月时,与对照组饮食相比,LCD取得了更高的糖尿病缓解率(HbA1c<6.5%)(76/133(57%)vs 41/131(31%);风险差异0.32)。

6个月和12个月LCD和VLCD饮食HbA1c和体重变化的差异

6个月时,体重减轻、甘油三酯和胰岛素敏感性都有较大临床意义的改善,但在12个月时差异减少。同时,VLCD在6个月时对体重减轻的效果不如限制性较低的LCD。然而,这种影响是由饮食的依从性解释的。也就是说,高度坚持VLCD的患者较不太坚持的人体重有了临床意义的减少。

由此可见,坚持6个月低碳水饮食的患者糖尿病的缓解率较高,而不会产生不良后果。

 

参考文献:

Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.m4743

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1849268, encodeId=6919184926841, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Nov 27 08:25:14 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971260, encodeId=38669e1260ed, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJGCjMHxibsI7tknxuIibFrgcdq4wLameMcwsXDccTsBdqGd7sv3gmmTVsOVsHlvcImnPZicB4CdAticg/132, createdBy=4c8a5229064, createdName=潘4190, createdTime=Sun Jun 06 10:32:39 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971245, encodeId=12279e12454b, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56ef5464082, createdName=ms8000000764578948, createdTime=Sun Jun 06 08:20:25 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971114, encodeId=d8b59e111430, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39ac5514057, createdName=ms1000001426910883, createdTime=Sat Jun 05 14:01:27 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043627, encodeId=543c104362e0a, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Jun 05 13:25:14 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971097, encodeId=bd019e1097f7, content=zsbd, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32525514007, createdName=ms9000001174761769, createdTime=Sat Jun 05 12:17:05 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971096, encodeId=de509e109685, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78695470120, createdName=ms2000001741638107, createdTime=Sat Jun 05 12:15:51 CST 2021, time=2021-06-05, status=1, ipAttribution=)]
    2021-11-27 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1849268, encodeId=6919184926841, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Nov 27 08:25:14 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971260, encodeId=38669e1260ed, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJGCjMHxibsI7tknxuIibFrgcdq4wLameMcwsXDccTsBdqGd7sv3gmmTVsOVsHlvcImnPZicB4CdAticg/132, createdBy=4c8a5229064, createdName=潘4190, createdTime=Sun Jun 06 10:32:39 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971245, encodeId=12279e12454b, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56ef5464082, createdName=ms8000000764578948, createdTime=Sun Jun 06 08:20:25 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971114, encodeId=d8b59e111430, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39ac5514057, createdName=ms1000001426910883, createdTime=Sat Jun 05 14:01:27 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043627, encodeId=543c104362e0a, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Jun 05 13:25:14 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971097, encodeId=bd019e1097f7, content=zsbd, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32525514007, createdName=ms9000001174761769, createdTime=Sat Jun 05 12:17:05 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971096, encodeId=de509e109685, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78695470120, createdName=ms2000001741638107, createdTime=Sat Jun 05 12:15:51 CST 2021, time=2021-06-05, status=1, ipAttribution=)]
    2021-06-06 潘4190

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1849268, encodeId=6919184926841, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Nov 27 08:25:14 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971260, encodeId=38669e1260ed, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJGCjMHxibsI7tknxuIibFrgcdq4wLameMcwsXDccTsBdqGd7sv3gmmTVsOVsHlvcImnPZicB4CdAticg/132, createdBy=4c8a5229064, createdName=潘4190, createdTime=Sun Jun 06 10:32:39 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971245, encodeId=12279e12454b, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56ef5464082, createdName=ms8000000764578948, createdTime=Sun Jun 06 08:20:25 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971114, encodeId=d8b59e111430, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39ac5514057, createdName=ms1000001426910883, createdTime=Sat Jun 05 14:01:27 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043627, encodeId=543c104362e0a, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Jun 05 13:25:14 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971097, encodeId=bd019e1097f7, content=zsbd, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32525514007, createdName=ms9000001174761769, createdTime=Sat Jun 05 12:17:05 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971096, encodeId=de509e109685, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78695470120, createdName=ms2000001741638107, createdTime=Sat Jun 05 12:15:51 CST 2021, time=2021-06-05, status=1, ipAttribution=)]
    2021-06-06 ms8000000764578948

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1849268, encodeId=6919184926841, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Nov 27 08:25:14 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971260, encodeId=38669e1260ed, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJGCjMHxibsI7tknxuIibFrgcdq4wLameMcwsXDccTsBdqGd7sv3gmmTVsOVsHlvcImnPZicB4CdAticg/132, createdBy=4c8a5229064, createdName=潘4190, createdTime=Sun Jun 06 10:32:39 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971245, encodeId=12279e12454b, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56ef5464082, createdName=ms8000000764578948, createdTime=Sun Jun 06 08:20:25 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971114, encodeId=d8b59e111430, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39ac5514057, createdName=ms1000001426910883, createdTime=Sat Jun 05 14:01:27 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043627, encodeId=543c104362e0a, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Jun 05 13:25:14 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971097, encodeId=bd019e1097f7, content=zsbd, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32525514007, createdName=ms9000001174761769, createdTime=Sat Jun 05 12:17:05 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971096, encodeId=de509e109685, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78695470120, createdName=ms2000001741638107, createdTime=Sat Jun 05 12:15:51 CST 2021, time=2021-06-05, status=1, ipAttribution=)]
    2021-06-05 ms1000001426910883

    挺好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1849268, encodeId=6919184926841, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Nov 27 08:25:14 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971260, encodeId=38669e1260ed, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJGCjMHxibsI7tknxuIibFrgcdq4wLameMcwsXDccTsBdqGd7sv3gmmTVsOVsHlvcImnPZicB4CdAticg/132, createdBy=4c8a5229064, createdName=潘4190, createdTime=Sun Jun 06 10:32:39 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971245, encodeId=12279e12454b, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56ef5464082, createdName=ms8000000764578948, createdTime=Sun Jun 06 08:20:25 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971114, encodeId=d8b59e111430, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39ac5514057, createdName=ms1000001426910883, createdTime=Sat Jun 05 14:01:27 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043627, encodeId=543c104362e0a, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Jun 05 13:25:14 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971097, encodeId=bd019e1097f7, content=zsbd, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32525514007, createdName=ms9000001174761769, createdTime=Sat Jun 05 12:17:05 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971096, encodeId=de509e109685, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78695470120, createdName=ms2000001741638107, createdTime=Sat Jun 05 12:15:51 CST 2021, time=2021-06-05, status=1, ipAttribution=)]
    2021-06-05 misszhang

    谢谢MedSci提供最新的资讯

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1849268, encodeId=6919184926841, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Nov 27 08:25:14 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971260, encodeId=38669e1260ed, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJGCjMHxibsI7tknxuIibFrgcdq4wLameMcwsXDccTsBdqGd7sv3gmmTVsOVsHlvcImnPZicB4CdAticg/132, createdBy=4c8a5229064, createdName=潘4190, createdTime=Sun Jun 06 10:32:39 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971245, encodeId=12279e12454b, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56ef5464082, createdName=ms8000000764578948, createdTime=Sun Jun 06 08:20:25 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971114, encodeId=d8b59e111430, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39ac5514057, createdName=ms1000001426910883, createdTime=Sat Jun 05 14:01:27 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043627, encodeId=543c104362e0a, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Jun 05 13:25:14 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971097, encodeId=bd019e1097f7, content=zsbd, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32525514007, createdName=ms9000001174761769, createdTime=Sat Jun 05 12:17:05 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971096, encodeId=de509e109685, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78695470120, createdName=ms2000001741638107, createdTime=Sat Jun 05 12:15:51 CST 2021, time=2021-06-05, status=1, ipAttribution=)]
    2021-06-05 ms9000001174761769

    zsbd

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1849268, encodeId=6919184926841, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Nov 27 08:25:14 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971260, encodeId=38669e1260ed, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJGCjMHxibsI7tknxuIibFrgcdq4wLameMcwsXDccTsBdqGd7sv3gmmTVsOVsHlvcImnPZicB4CdAticg/132, createdBy=4c8a5229064, createdName=潘4190, createdTime=Sun Jun 06 10:32:39 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971245, encodeId=12279e12454b, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56ef5464082, createdName=ms8000000764578948, createdTime=Sun Jun 06 08:20:25 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971114, encodeId=d8b59e111430, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39ac5514057, createdName=ms1000001426910883, createdTime=Sat Jun 05 14:01:27 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043627, encodeId=543c104362e0a, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Jun 05 13:25:14 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971097, encodeId=bd019e1097f7, content=zsbd, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32525514007, createdName=ms9000001174761769, createdTime=Sat Jun 05 12:17:05 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971096, encodeId=de509e109685, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78695470120, createdName=ms2000001741638107, createdTime=Sat Jun 05 12:15:51 CST 2021, time=2021-06-05, status=1, ipAttribution=)]
    2021-06-05 ms2000001741638107

    学习

    0

拓展阅读

最新研究:效果媲美降糖药,仅需每日控碳水到这个量即可

2023年美国糖尿病协会年会上公布了一项探索低碳水化合物饮食干预对2型糖尿病的效果研究,表明低碳水化合物饮食的控糖效果不劣于卡格列净,且患者糖化血红蛋白水平下降幅度更大。

J RENAL NUTR:“低碳水饮食”不仅在减肥者中很受欢迎,对慢性CKD患者来说同样获益匪浅!

LCD评分与慢性肾脏病成人的全因死亡率呈显著正相关,但与无慢性肾脏病成人的全因死亡率无显著正相关。

JCEM:2型糖尿病患者适度低碳水化合物饮食与死亡率的关系

健康的低碳水化合物饮食评分与T2D成人死亡率降低显著相关。坚持均衡适度的低碳水化合物饮食,强调了健康的碳水化合物、植物性蛋白质和多不饱和脂肪,可防止T2D患者过早死亡。

Diabetes Obes Metab:低碳水化合物饮食对肥胖个体长期减肥的疗效

与非碳水化合物限制饮食相比,低碳水化合物饮食与更大的短期体重减轻相关,并对心血管风险因素有长期有利的影响。

J Urol:低碳水化合物饮食与前列腺癌的心血管和代谢综合征风险评估

代谢综合征(MetS)在美国很普遍,包括了心血管疾病(CVD)的多种风险因素,并且可能与前列腺癌有关 。此外,MetS可能与更差的前列腺癌结局有关,特别是更具侵略性的肿瘤特征和生化复发。联系MetS和

BMJ:低和超低碳水化合物饮食可缓解糖尿病

在达成共识之前,研究人员应该清楚他们对低碳水化合物和超低碳水化合物饮食以及糖尿病缓解的先验定义,应该知道文献中使用了哪些定义,同时认识到任何敏感性或用于比较不同定义的结果的亚组分析。